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been in contact with people with fever
for several weeks before his illness.
He lived in close proximity to goats
and cattle, but no blood samples were
taken from these animals. Although
no ticks were found on nearby goats,
10 Amblyomma and Hyalomma ticks
were collected from three cattle. Ticks
were negative for CCHF virus isola-
tion on suckling mice and RT-PCR
amplification.
No other case of fever accompa-
nied by hemorrhage was reported in
the area, and none of the patient’s 14
close contacts became ill. Of the four
close contacts from whom blood sam-
ples were taken, analyses for IgM and
IgG antibodies against CCHF virus
were negative by ELISA. 
While no clinical case of CCHF
has ever been reported in Senegal,
studies dating from 1969 indicate that
CCHF virus had been found in vari-
ous locations in the country (2,3). In
the village of Bandia, in the same dis-
trict where the reported case was
observed, a study conducted from
1986 to 1988 showed a prevalence of
anti-CCHF IgG of 3.2% in the human
population (4). Another study, con-
ducted in the same area from 1989 to
1992, showed seroconversions for
several ruminants and isolated the
virus from ticks (5).
During CCHF outbreaks, an aver-
age of 30% of people who had the dis-
ease died (case-fatality ratio). It is
often discovered during nosocomial
outbreaks, as was the case in
Mauritania, a country on Sénégal’s
northern border, in 2003 (P. Nabeth,
unpub. data). To prevent outbreaks of
CCHF, public awareness campaigns
aimed at the populations most at
risk—livestock farmers, butchers, and
health personnel—must be conduct-
ed, and the epidemiologic alert sys-
tems must be strengthened. In addi-
tion, conditions that enhance mainte-
nance of the virus in nature and its
transmission to humans must be better
understood so adequate control meas-
ures can be developed.
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Influenza among
U.K. Pilgrims to
Hajj, 2003
To the Editor: Each year, approx-
imately 2 million Muslims travel from
all over the world to participate in
hajj. Approximately 22,000 pilgrims
travel from the United Kingdom to
Makkah, Saudi Arabia; of those,
approximately 1,000 person reside in
the east end of London. In the past,
infectious diseases research conduct-
ed during these pilgrimages focused
on meningococcal disease because of
outbreaks associated with the hajj.
Since 2000, the dates of the hajj have
been moved back into the winter sea-
son; this time change could lead to a
seasonal increase in outbreaks of res-
piratory infections caused by influen-
za and other viruses. From 1991 to
1992, influenza A was a common
cause of respiratory infection in pil-
grims tested in Makkah (1).However,
the incidence rate of influenza among
pilgrims from Europe is not well-
known. Aprevious study of influenza-
like illness among pilgrims from
Pakistan reported rates of 36% in
influenza-vaccinated pilgrims and
62% in influenza-nonvaccinated pil-
grims; these results were based on
clinical endpoints without microbio-
logic confirmation (2).
We assessed the risk for influenza
infection among a cohort of pilgrims
from the east end of London who par-
ticipated in the hajj in 2003. From
December 2002 to January 2003, we
enrolled 115 participants who planned
to take part in hajj in 2003. The
study was approved by the North
London Multicentre Research Ethics
Committee and the Trustees of East
London Mosque. Informed consent
was obtained through appropriate
translators. All participants attended
the East London Mosque, White-
chapel, London; 30 were vaccinated
with influenza vaccine (A/New
Caledonia/20/99 [H1N1]-like strain, A
/Moscow/10/99 [H3N2]-like strain,
B/Sichuan/379/99-like strain). Venous
blood samples were collected, and
questionnaires were completed before
the participants departed for the hajj
and within 2–3 weeks of their return in
February to March 2003.
Tests for influenza A and B were
conducted by using hemagglutinationLETTERS
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inhibition against the following
influenza antigens: A/NewCalidonia/
20/99, A/Wuhan/371/91, A/Sydney/5/
97, A/Panama/2007/99, B/Sichuan/
379/99, and B/Harbin/7/94. A diagno-
sis of influenza was made based on
seroconversion with at least a fourfold
rise in antibody titer. Based on sero-
conversion, the influenza attack rate
among all pilgrims was 38% (44/115).
The attack rate was 30% among the
vaccinated and 41% among the non-
vaccinated participants (Table) (odds
ratio for influenza in vaccinees =
0.61, p = 0.28). Of the 44 patients, 42
(37%) were infected with influenza A
H3N2; 1 had influenza AH1N1, and 1
had influenza B infection. Six influen-
za A H3N2 patients were dually
infected; two patients seroconverted
to AH1N1, and four patients serocon-
verted to influenza B. Nearly half
(21/44) of the patients with influenza
received a course of antimicrobial
drugs while on the hajj compared with
38% (27/71) of those who did not
seroconvert. The attack rate in the
vaccinated patients was lower than
the rate in nonvaccinated patients,
which is consistent with some protec-
tive effect of the influenza vaccine. 
Even though blood was collected
from five convalescing patients with-
in 3 weeks of their return from the
hajj, some of the patients may have
acquired influenza B infection imme-
diately after their return to the United
Kingdom, as it was the main strain
circulating in the United Kingdom in
late February to March 2003. Many
pilgrims from throughout the world,
some of whom may carry H3N2 drift
variants, mingle closely during the
hajj. This type of exposure increases
the risk for worldwide spread of new
drift variants and other contagious
respiratory diseases (3). Given the
potential for the high influenza attack
rate documented in this study, all pil-
grims, regardless of age, should be
offered influenza vaccination before
they travel on the hajj during winter
months. On-site testing for influenza
should be available to medical servic-
es in Makkah (and countries of ori-
gin), and treatment with a neu-
raminidase inhibitor should be offered
to persons who test positive and have
been symptomatic for <48 hours (4).
This treatment should lessen the
transmission risk to pilgrims during
the crowded events during travel and
on their return home (5). When pil-
grims return from the hajj, physicians
should be informed that pilgrims may
bring back new drift variants of
influenza; physicians should consider
the diagnosis and treat persons at risk
and their close contacts (4).
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Streptomyces 
thermovulgaris
Bacteremia in
Crohn’s Disease
Patient
To the Editor: Invasive infections
with  Streptomyces  spp. are rare; in
reference to two cases reported in
Emerging Infectious Diseases (1,2),
we describe here the first documented
case of bacteremia with Streptomyces
thermovulgaris. An 81-year-old
woman was admitted to the emer-
gency room of Diakonessenhuis,
Utrecht, the Netherlands, with severe
abdominal pain in the right lower
quadrant and feculent vomitus. The
patient had a history of Crohn’s dis-
ease, for which she had undergone
resection of the ileum and cecum, and
was receiving high-dose corticos-
teroid therapy (prednisone 25 mg